SIRT3 and breast cancer: In cultured colon cell lines, a deficiency in SIRT3 increases apoptosis, while reducing cell proliferation, invasion, and migration [56], whereas breast cancer cells with upregulated SIRT3 exhibit decreased glycolysis and proliferation, providing a metabolic route for tumor suppression [57].